Breaking News: GSK – Market Insights, Analysis & Latest Updates

Analysis-GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up

U.S. sales of RSV vaccines from GSK and Pfizer have declined significantly due to narrowed eligibility, impacting demand and sales expectations for both companies.

investing.com • 08/10/2024 - 10:54 AM

GILD
GSK

Pharma firms eye growth with HIV long-acting treatments: HSBC

HSBC discusses Gilead and GSK's focus on long-acting HIV treatments, highlighting efficacy, market potential, competition, and future developments in the HIV treatment landscape.

investing.com • 04/10/2024 - 15:57 PM

Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply

GSK, Sanofi, and CSL received $72 million from the U.S. government to boost bird flu vaccine production amid a recent outbreak affecting livestock and poultry.

investing.com • 04/10/2024 - 15:08 PM

GSK shares rise on Delaware Supreme Court appeal in Zantac case

GSK shares increased after the Delaware Supreme Court agreed to review a decision permitting expert evidence in a trial linked to ranitidine's alleged cancer risks.

investing.com • 28/08/2024 - 08:30 AM

Greed and Fear Index

Note: The data is for reference only.

Fear

Analysis-GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up

Pharma firms eye growth with HIV long-acting treatments: HSBC

Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply

GSK shares rise on Delaware Supreme Court appeal in Zantac case

Currency